Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1599 results found

2024 ∙ Censi, S. Bisaccia, G. Gallina, S. Tomassini, V. Uncini, A.

Guillain-Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Hadhiah, K. Alhashim, A. Al-Dandan, H. A. Alhassan, E. Alqarni, A. M. Memish, A. A. A. Alabdali, M.

Guillain-Barré syndrome post-SARS-CoV-2 vaccine: a systematic review and data analysis on its clinical, laboratory, electrophysiological, and radiological features

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Mitsikostas, D. D. Caronna, E. De Tommaso, M. Deligianni, C. I. Ekizoglu, E. Bolay, H. Göbel, C. H. Kristoffersen, E. S. Lampl, C. Moro, E. Pozo-Rosich, P. Sellner, J. Terwindt, G. Sieira, P. I.

Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Asante, M. A. Michelsen, M. E. Balakumar, M. M. Kumburegama, B. Sharifan, A. Thomsen, A. R. Korang, S. K. Gluud, C. Menon, S.

Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Alpeza, F. Avermark, H. Gobbo, E. Herzig van Wees, S.

How has co-design been used to address vaccine hesitancy globally? A systematic review

  • All age groups
  • Human papillomavirus (HPV)
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Herieka, H. Babalis, D. Tzala, E. Budhathoki, S. Johnson, N. A.

How inclusive were UK-based randomised controlled trials of COVID-19 vaccines? A systematic review investigating enrolment of Black adults and adult ethnic minorities

  • Europe
  • United Kingdom
  • All age groups
  • COVID-19
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Li, X. Z. Li, Y. W. Huang, C. Y. Liu, J. L. Liu, R. B. Zhang, Z. X. Yan, J. Z. Zhang, C.

Humoral immunity and safety of respiratory virus vaccines in systemic lupus erythematosus population: a meta-analysis based on twenty-five observational studies

  • Adults
  • Older adults
  • COVID-19
  • Influenza
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Alper, L. Oron, Y. Handzel, O. Abu-Eta, R. Muhanna, N. Ungar, O. J.

Idiopathic sudden sensorineural hearing loss after COVID-19 vaccination: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Lamichhane, P. Khalid, H. Siviyachan, C. K. Zafar, S. Prasanth, M. Khanal, K. Agrawal, A. Kaur Jhajj, L.

Immediate impacts of COVID-19 vaccination on glycemic control in type 1 diabetes mellitus: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Hua, T. Fan, R. Fan, Y. Chen, F.

Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...